{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:32:16Z","timestamp":1776436336022,"version":"3.51.2"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Sepsis causes a high rate of mortality and long-term morbidity, associated with an imbalance of innate immunity against infections and inflammation. Obesity and diabetes increase the risk for disease severity. Monocyte dysfunction plays a major role and justify further investigations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the distribution and inflammatory phenotypes in circulating monocyte subsets in patients manifesting with sepsis including septic shock with and without obesity and diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 235 blood samples were tested from critically ill adult patients registered at the intensive care unit (ICU). The cohorts were divided into non-diabetic groups with or without obesity and diabetic groups with or without obesity, suffering from sepsis or septic shock. We determined frequencies of total monocytes and of monocyte subsets in the circulation and density expression levels of functional markers, including CD14, CD16, HLA-DR, CD33, CD163, CD206, and arginase-1 by flow cytometric analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>When progressing to septic shock in non-diabetic and diabetic patients, the percentages of total monocytes among the leukocyte population and of CD33+ and CD14+ monocytes among the monocyte population were consistently down-regulated compared to non-sepsis in non-diabetic and diabetic patients, respectively. Non-diabetic sepsis patients further presented with decreased CD33 and up-regulated CD163 expression density, which was absent in diabetic patients. We subsequently addressed obesity-related changes of monocytes in non-diabetic and diabetic septic patients. Obese septic patients with diabetes were unique in displaying increased monocytic CD16 and CD163 expression. However, obese septic patients without diabetes solely presented with lower amounts of non-classical monocytes. Body mass index (BMI) dependent changes were restricted to diabetic septic patients, with a significantly higher diminution of the classical monocyte subset and concomitantly increased CD16 expression densities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Distribution and phenotypes of monocyte subsets were differentially modulated in critically ill patients with and without metabolic disease when progressing to sepsis or septic shock. Only diabetic septic patients displayed decline of classical monocytes and increase of CD16 expression densities. Therefore, diabetes but not obesity appears to promote the inflammatory phenotype of circulating monocytes in critically ill patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1026298","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T11:41:47Z","timestamp":1672918907000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Monocyte subtype expression patterns in septic patients with diabetes are distinct from patterns observed in obese patients"],"prefix":"10.3389","volume":"9","author":[{"given":"Dan","family":"Ning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Schick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Bracht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Barth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Marion","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01511","article-title":"Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome.","volume":"9","author":"Hawkins","year":"2018","journal-title":"Front Immunol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00271","article-title":"Diabetes and sepsis: risk, recurrence, and ruination.","volume":"8","author":"Frydrych","year":"2017","journal-title":"Front Endocrinol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040.","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/JLB.5VMR0118-021RR","article-title":"Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality.","volume":"104","author":"Frydrych","year":"2018","journal-title":"J Leukoc Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/SHK.0000000000000778","article-title":"Diabetes mellitus and sepsis: a challenging association.","volume":"47","author":"Trevelin","year":"2017","journal-title":"Shock."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jama.2016.2691","article-title":"Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis.","volume":"315","author":"van Vught","year":"2016","journal-title":"JAMA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","article-title":"Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets.","volume":"118","author":"Wong","year":"2011","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/JLB.MR0318-104R","article-title":"Long-term reprogramming of the innate immune system.","volume":"105","author":"Dominguez-Andres","year":"2019","journal-title":"J Leukoc Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+ CD16+ blood monocytes: their role in infection and inflammation.","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J Leukoc Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7326\/0003-4819-88-1-78","article-title":"UCLA conference. monocytes and macrophages: functions and diseases.","volume":"88","author":"Cline","year":"1978","journal-title":"Ann Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/ATVBAHA.116.308198","article-title":"Monocyte conversion during inflammation and injury.","volume":"37","author":"Kratofil","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity.","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1182\/blood.V82.10.3170.3170","article-title":"The novel subset of CD14+\/CD16+ blood monocytes is expanded in sepsis patients.","volume":"82","author":"Fingerle","year":"1993","journal-title":"Blood."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.900284","article-title":"Monocytic subsets impact cerebral cortex and cognition: differences between healthy subjects and patients with first-episode schizophrenia.","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock.","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus.","volume":"33","year":"2010","journal-title":"Diabetes Care."},{"key":"B17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"key":"B18","first-page":"1","article-title":"Obesity: preventing and managing the global epidemic. report of a WHO consultation.","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation.","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg."},{"key":"B20","author":"Lenhard","year":"2016","journal-title":"Computation of effect sizes."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs.","volume":"4","author":"Lakens","year":"2013","journal-title":"Front Psychol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/cc7969","article-title":"Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis.","volume":"13","author":"Poehlmann","year":"2009","journal-title":"Crit Care."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013038","article-title":"Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes.","volume":"12","author":"Alzaid","year":"2020","journal-title":"EMBO Mol Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/s0002-9149(00)00757-8","article-title":"Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD14 expression.","volume":"85","author":"Pati\u00f1o","year":"2000","journal-title":"Am J Cardiol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.60849","article-title":"CD14 release induced by P2X7 receptor restricts inflammation and increases survival during sepsis.","volume":"9","author":"Alarc\u00f3n-Vila","year":"2020","journal-title":"eLife."},{"key":"B26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/01.shk.0000217815.57727.29","article-title":"TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock.","volume":"25","author":"Brunialti","year":"2006","journal-title":"Shock."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance.","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.4049\/jimmunol.1402655","article-title":"Profiling of the three circulating monocyte subpopulations in human obesity.","volume":"194","author":"Dev\u00eavre","year":"2015","journal-title":"J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ni.3398","article-title":"Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.","volume":"17","author":"Cheng","year":"2016","journal-title":"Nat Immunol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01761","article-title":"A novel, five-marker alternative to cd16-cd14 gating to identify the three human monocyte subsets.","volume":"10","author":"Ong","year":"2019","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/ATVBAHA.111.230979","article-title":"CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis.","volume":"31","author":"Poitou","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.18632\/aging.101465","article-title":"Age-related M1\/M2 phenotype changes in circulating monocytes from healthy\/unhealthy individuals.","volume":"10","author":"Costantini","year":"2018","journal-title":"Aging."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01874","article-title":"Perturbation of the monocyte compartment in human obesity.","volume":"10","author":"Friedrich","year":"2019","journal-title":"Front Immunol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/649083","article-title":"Alterations in monocyte CD16 in association with diabetes complications.","volume":"2012","author":"Min","year":"2012","journal-title":"Mediators Inflamm."},{"key":"B35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1046\/j.1365-3083.2002.01092.x","article-title":"CD14+CD16+ monocytes in the course of sepsis in neonates and small children: monitoring and functional studies.","volume":"55","author":"Skrzeczy\u00f1ska","year":"2002","journal-title":"Scand J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1182\/blood-2017-03-771261","article-title":"Circulatory and maturation kinetics of human monocyte subsets in vivo.","volume":"130","author":"Tak","year":"2017","journal-title":"Blood."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-1977-1","article-title":"Increases in inflammatory and CD14dim\/CD16pos\/CD45pos patrolling monocytes in sepsis: correlation with final outcome.","volume":"22","author":"Gainaru","year":"2018","journal-title":"Crit Care."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.4049\/jimmunol.1100244","article-title":"CD16 regulates TRIF-dependent TLR4 response in human monocytes and their subsets.","volume":"188","author":"Shalova","year":"2012","journal-title":"J Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jss.2013.11.004","article-title":"CD16 inhibition increases host survival in a murine model of severe sepsis.","volume":"187","author":"Zhang","year":"2014","journal-title":"J Surg Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.4049\/jimmunol.168.7.3536","article-title":"The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.","volume":"168","author":"Belge","year":"2002","journal-title":"J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/eji.200425273","article-title":"Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.","volume":"35","author":"Lajaunias","year":"2005","journal-title":"Eur J Immunol."},{"key":"B42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V96.2.483.014k40_483_490","article-title":"Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.","volume":"96","author":"Paul","year":"2000","journal-title":"Blood."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2006-05-023556","article-title":"CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover.","volume":"109","author":"Orr","year":"2007","journal-title":"Blood."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-13-19","article-title":"High glucose concentrations induce TNF-\u03b1 production through the down-regulation of CD33 in primary human monocytes.","volume":"13","author":"Gonzalez","year":"2012","journal-title":"BMC Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1097\/CCM.0000000000001650","article-title":"Admission hyperglycemia in critically ill sepsis patients: association with outcome and host response.","volume":"44","author":"van Vught","year":"2016","journal-title":"Crit Care Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1161\/01.cir.0000034509.14906.ae","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.","volume":"106","author":"Esposito","year":"2002","journal-title":"Circulation."},{"key":"B47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jdiacomp.2005.09.006","article-title":"Decreased production of inflammatory cytokines by circulating monocytes and dendritic cells in type 2 diabetic men with atherosclerotic complications.","volume":"21","author":"Corrales","year":"2007","journal-title":"J Diabetes Complicat."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/816460","article-title":"Understanding the mysterious M2 macrophage through activation markers and effector mechanisms.","volume":"2015","author":"R\u0151szer","year":"2015","journal-title":"Mediators Inflamm."},{"key":"B49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1365-2362.2009.02170.x","article-title":"Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity.","volume":"39","author":"Sporrer","year":"2009","journal-title":"Eur J Clin Invest."},{"key":"B50","doi-asserted-by":"publisher","first-page":"641","DOI":"10.33549\/physiolres.933522","article-title":"An alternatively activated macrophage marker CD163 in severely obese patients: the influence of very low-calorie diet and bariatric surgery.","volume":"66","author":"Cinkajzlov\u00e1","year":"2017","journal-title":"Physiol Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/cyto.b.21321","article-title":"CD163 and CD206 expression does not correlate with tolerance and cytokine production in LPS-tolerant human monocytes.","volume":"92","author":"Alves-Januzzi","year":"2017","journal-title":"Cytometry B Clin Cytom."},{"key":"B52","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037393","article-title":"Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis.","volume":"7","author":"Brunialti","year":"2012","journal-title":"PLoS One."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-021-00215-2","article-title":"Macrophage function in the elderly and impact on injury repair and cancer.","volume":"18","author":"Duong","year":"2021","journal-title":"Immun Ageing."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838636","article-title":"Single cell transcriptome and surface epitope analysis of ankylosing spondylitis facilitates disease classification by machine learning.","volume":"13","author":"Alber","year":"2022","journal-title":"Front Immunol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11546-6","article-title":"Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis.","volume":"21","author":"Cai","year":"2021","journal-title":"BMC Public Health."},{"key":"B57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.120.051936","article-title":"Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results From the American heart association COVID-19 cardiovascular disease registry.","volume":"143","author":"Hendren","year":"2021","journal-title":"Circulation."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1026298\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T11:41:54Z","timestamp":1672918914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1026298\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,5]]},"references-count":57,"alternative-id":["10.3389\/fmed.2022.1026298"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1026298","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,5]]},"article-number":"1026298"}}